Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Quinapril

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 11 USDMF, 4 CEP/COS, 5 EU WC, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

200 FDF Dossiers, 77 FDA Orange Book, 90 Europe, 4 Canada, 3 Australia, 26 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 9 SPI Pharma, 13 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 31 BASF, 1 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 5 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 15 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 32 Controlled & Modified Release, 30 Direct Compression, 30 Thickeners and Stabilizers, 28 Granulation, 21 Disintegrants & Superdisintegrants, 17 Solubilizers, 16 Lubricants & Glidants, 14 Co-Processed Excipients, 13 Film Formers & Plasticizers, 12 Topical, 10 Chewable & Orodispersible Aids, 10 Taste Masking, 9 Empty Capsules, 8 Rheology Modifiers, 7 API Stability Enhancers, 6 Parenteral, 5 Emulsifying Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

16 News #PharmaBuzz

16 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 53 Regulatory FDF Prices

MARKET PLACE

6 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

32 Health Canada Patents

32 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 3 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/03/2025	Aarti Pharmalabs	India	AARTI PHARMALABS LIMITED Mulund (W), Mumbai IN	R1-CEP 2016-100 - Rev 00	Quinapril hydrochloride	2023-02-01	Valid	Chemical		1763
28/03/2025	Aurobindo Pharma Limited	India	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	CEP 2013-160 - Rev 02	Quinapril hydrochloride	2023-11-16	Valid	Chemical		1763

Quinapril

Quinapril

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers

11 USDMF

4 CEP/COS

5 EU WC

5 NDC API

6 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

200 FDF Dossiers

77 FDA Orange Book

90 Europe

4 Canada

3 Australia

26 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

9 SPI Pharma

13 DKSH

1 Pharm-RX Chemical

5 Faran Shimi Pharmaceutical

10 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

4 ACG Worldwide

4 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

31 BASF

1 Clariant

10 Corel Pharma Chem

4 DFE Pharma

1 Finar

9 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

7 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

32 Kerry

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nomisma Healthcare

5 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

15 Roquette

7 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

10 Sigachi Industries

2 The Dow Chemical Company

2 Ulanqab Kema New Material

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders

54 Coating Systems & Additives

32 Controlled & Modified Release

30 Direct Compression

30 Thickeners and Stabilizers

28 Granulation

21 Disintegrants & Superdisintegrants

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons